Literature DB >> 33895080

Clinical practice guidelines for recurrent miscarriage in high-income countries: a systematic review.

Marita Hennessy1, Rebecca Dennehy2, Sarah Meaney3, Laura Linehan2, Declan Devane4, Rachel Rice5, Keelin O'Donoghue2.   

Abstract

Recurrent miscarriage affects 1-2% of women of reproductive age, depending on the definition used. A systematic review was conducted to identify, appraise and describe clinical practice guidelines (CPG) published since 2000 for the investigation, management, and/or follow-up of recurrent miscarriage within high-income countries. Six major databases, eight guideline repositories and the websites of 11 professional organizations were searched to identify potentially eligible studies. The quality of eligible CPG was assessed using the Appraisal of Guidelines for Research and Evaluation (AGREE II) Tool. A narrative synthesis was conducted to describe, compare and contrast the CPG and recommendations therein. Thirty-two CPG were included, from which 373 recommendations concerning first-trimester recurrent miscarriage were identified across four sub-categories: structure of care (42 recommendations, nine CPG), investigations (134 recommendations, 23 CPG), treatment (153 recommendations, 24 CPG), and counselling and supportive care (46 recommendations, nine CPG). Most CPG scored 'poor' on applicability (84%) and editorial independence (69%); and to a lesser extent stakeholder involvement (38%) and rigour of development (31%). Varying levels of consensus were found across CPG, with some conflicting recommendations. Greater efforts are required to improve the quality of evidence underpinning CPG, the rigour of their development and the inclusion of multi-disciplinary perspectives, including those with lived experience of recurrent miscarriage.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  AGREE II; Clinical guidelines; Early pregnancy loss; Miscarriage; Recurrent miscarriage; Systematic review

Mesh:

Year:  2021        PMID: 33895080     DOI: 10.1016/j.rbmo.2021.02.014

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  5 in total

1.  Blood serum lipid profiling may improve the management of recurrent miscarriage: a combination of machine learning of mid-infrared spectra and biochemical assays.

Authors:  Zozan Guleken; Pınar Yalçın Bahat; Ömer Faruk Toto; Huri Bulut; Paweł Jakubczyk; Jozef Cebulski; Wiesław Paja; Krzysztof Pancerz; Agnieszka Wosiak; Joanna Depciuch
Journal:  Anal Bioanal Chem       Date:  2022-10-13       Impact factor: 4.478

2.  Diagnosing chronic endometritis: when simplification fails to clarify.

Authors:  Maximilian Murtinger; Barbara Wirleitner; Dietmar Spitzer; Helena Bralo; Susanna Miglar; Maximilian Schuff
Journal:  Hum Reprod Open       Date:  2022-06-07

3.  Developing guideline-based key performance indicators for recurrent miscarriage care: lessons from a multi-stage consensus process with a diverse stakeholder group.

Authors:  Marita Hennessy; Laura Linehan; Rebecca Dennehy; Declan Devane; Rachel Rice; Sarah Meaney; Keelin O'Donoghue
Journal:  Res Involv Engagem       Date:  2022-05-14

4.  Chief Editor's 2021 annual report.

Authors:  Bart C J M Fauser; Duncan Nicholas; Kamal Ahuja
Journal:  Reprod Biomed Online       Date:  2022-05       Impact factor: 3.828

5.  Inhibition of HMGB1 Ameliorates the Maternal-Fetal Interface Destruction in Unexplained Recurrent Spontaneous Abortion by Suppressing Pyroptosis Activation.

Authors:  Damin Zhu; Huijuan Zou; Jinxian Liu; Jing Wang; Cong Ma; Jiaqian Yin; Xiaoqing Peng; Danyang Li; Yulu Yang; Yu Ren; Zhiguo Zhang; Ping Zhou; Xiangyan Wang; Yunxia Cao; Xiaofeng Xu
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.